SHUKRAPHAR vs SUNLOC: Stock Comparison

SHUKRA PHARMACEUTICALS L vs SUNIL HEALTHCAREUpdated 17 Sept 26, 12:09 PM ISTNSE & company filings

SHUKRA PHARMACEUTICALS L shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SHUKRAPHAR leads 2; SUNLOC leads 1 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SHUKRAPHARSUNLOC

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
₹0 Cr
P/E RatioSame reading
63.03x
P/B RatioSame reading
21.83x
EPSSUNLOC has the higher reading
₹0.34
₹0.45
Book ValueContext only
₹2.05
₹67.87
Dividend YieldSHUKRAPHAR has the higher reading
0.02%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

EPS
SUNLOC has higher earnings per share
₹0.45 vs ₹0.34
Dividend Yield
SHUKRAPHAR has a higher dividend yield
0.02% vs 0%
Qtr Profit Growth
SHUKRAPHAR has stronger quarterly profit growth
15.98% vs -9.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricSHUKRAPHARSUNLOC
Live Price₹54.36₹73.49
Day Change-0.44%0%
Volume10.95 L0
52-Week High₹58.2₹82
52-Week Low₹40.06₹67.5
Distance from 52W High-6.6%-10.38%

Valuation

MetricSHUKRAPHARSUNLOC
Market Cap₹0 Cr₹0 Cr
P/E Ratio63.03x
P/B Ratio21.83x
EPS₹0.34₹0.45
Book Value₹2.05₹67.87
Dividend Yield0.02%0%

Growth

MetricSHUKRAPHARSUNLOC
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth15.98%-9.3%

Profitability & Leverage

MetricSHUKRAPHARSUNLOC
Net Margin0%0%

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSHUKRAPHARSUNLOC
Promoter Holding50.96%73.53%
FII Holding0%
DII Holding0.11%0.1%
Public Holding48.92% 0.01 pp26.37%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SHUKRA PHARMACEUTICALS L and SUNIL HEALTHCARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.